![Amazon.fr - Ocrelizumab: CD20, Monoclonal Antibody, B Cell - Surhone, Lambert M., Timpledon, Miriam T., Marseken, Susan F. - Livres Amazon.fr - Ocrelizumab: CD20, Monoclonal Antibody, B Cell - Surhone, Lambert M., Timpledon, Miriam T., Marseken, Susan F. - Livres](https://m.media-amazon.com/images/I/71ZeK9WzInL.jpg)
Amazon.fr - Ocrelizumab: CD20, Monoclonal Antibody, B Cell - Surhone, Lambert M., Timpledon, Miriam T., Marseken, Susan F. - Livres
![Brain Sciences | Free Full-Text | Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis Brain Sciences | Free Full-Text | Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis](https://www.mdpi.com/brainsci/brainsci-10-00333/article_deploy/html/images/brainsci-10-00333-g001.png)
Brain Sciences | Free Full-Text | Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis
Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls | PLOS ONE
Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program | PLOS ONE
![Roche's Ocrevus receives TGA approval for RMS and PPMS treatment in Australia - Pharmaceutical Technology Roche's Ocrevus receives TGA approval for RMS and PPMS treatment in Australia - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2017/09/main-1148.jpg)